Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Lixte Biotechnology Holdings Inc.
Headquarters: East Setauket, NY, United States of America
Website: http://www.lixte.com
Year Founded: 2005
Status: Public
Industry Sector: HealthTechnology
CEO: Bastiaan van der Baan
Number Of Employees: 4
Enterprise Value: $3,798,731
PE Ratio: -0.67
Exchange/Ticker 1: NASDAQ:LIXT
Exchange/Ticker 2: NASDAQ:LIXTW
Latest Market Cap: $3,220,900
BioCentury | Sep 30, 2021
Product Development
Gaucher disease pipeline: Data Byte
Three clinical and 11 preclinical candidates move beyond traditional enzyme replacement, aim for wider range of patients
BioCentury | Jul 28, 2017
Regulation
Ganging up in rare disease
What has to happen to implement EMA/FDA proposal for platform trials in rare disease
BioCentury | Jan 18, 2017
Translation in Brief
Keep a cool head
Neuro Pharmalogics is exploiting insect biology for orphan neurological diseases
BioCentury | Nov 2, 2015
Emerging Company Profile
Targeted disruption
PEP-Therapy's peptides block specific protein-protein interactions
BioCentury | Mar 23, 2015
Financial News
Lixte completes private placement of convertible preferred stock
Items per page:
1 - 10 of 15